
Anne Marie Falk
Examiner (ID: 427)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 685 |
| Issued Applications | 242 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7269874
[patent_doc_number] => 20040058392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition'
[patent_app_type] => new
[patent_app_number] => 10/246786
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4884
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246786 | Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6844660
[patent_doc_number] => 20030150007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Method of generating transgenic organisms using transposons'
[patent_app_type] => new
[patent_app_number] => 10/245441
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11581
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20030150007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245441 | Method of generating transgenic organisms using transposons | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6793541
[patent_doc_number] => 20030088885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Enhanced resolution of tumor metastasis using a skin flap model'
[patent_app_type] => new
[patent_app_number] => 10/241362
[patent_app_country] => US
[patent_app_date] => 2002-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3963
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10241362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/241362 | Enhanced resolution of tumor metastasis using a skin flap model | Sep 9, 2002 | Issued |
Array
(
[id] => 6862813
[patent_doc_number] => 20030093821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'DNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide,and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/236903
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6642
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20030093821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10236903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/236903 | DNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof | Sep 8, 2002 | Issued |
| 10/129897 | Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6685199
[patent_doc_number] => 20030121063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Compositions and methods of use of mammalian retrotransposons'
[patent_app_type] => new
[patent_app_number] => 10/216122
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 35700
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20030121063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10216122
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/216122 | Compositions and methods of use of mammalian retrotransposons | Aug 8, 2002 | Abandoned |
Array
(
[id] => 7605511
[patent_doc_number] => 07115418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Methods of proliferating undifferentiated neural cells'
[patent_app_type] => utility
[patent_app_number] => 10/199918
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 35820
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199918 | Methods of proliferating undifferentiated neural cells | Jul 18, 2002 | Issued |
Array
(
[id] => 6869826
[patent_doc_number] => 20030082515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Methods of screening biological agents'
[patent_app_type] => new
[patent_app_number] => 10/199189
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35744
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199189
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199189 | Methods of screening biological agents | Jul 18, 2002 | Issued |
Array
(
[id] => 6696814
[patent_doc_number] => 20030109008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Methods of making CDNA libraries'
[patent_app_type] => new
[patent_app_number] => 10/199830
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 36101
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199830
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199830 | Methods of making CDNA libraries | Jul 18, 2002 | Abandoned |
Array
(
[id] => 6329137
[patent_doc_number] => 20020198151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Intracellular inhibitors of Gq protein signaling'
[patent_app_type] => new
[patent_app_number] => 10/193234
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7148
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193234 | Intracellular inhibitors of Gq protein signaling | Jul 11, 2002 | Abandoned |
Array
(
[id] => 6774647
[patent_doc_number] => 20030017985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Molecules that influence pathogen resistance'
[patent_app_type] => new
[patent_app_number] => 10/169315
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28959
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169315 | Molecules that influence pathogen resistance | Jul 1, 2002 | Abandoned |
Array
(
[id] => 6823043
[patent_doc_number] => 20030221204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'BRI constructs and methods of using'
[patent_app_type] => new
[patent_app_number] => 10/185297
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11323
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20030221204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185297 | BRI constructs and methods of using | Jun 27, 2002 | Issued |
Array
(
[id] => 7679177
[patent_doc_number] => 20030167475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Methods for modulation of cholesterol transport'
[patent_app_type] => new
[patent_app_number] => 10/178611
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10400
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20030167475.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178611 | Methods for modulation of cholesterol transport | Jun 23, 2002 | Abandoned |
Array
(
[id] => 6260298
[patent_doc_number] => 20020187549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Derivation of pluripotential embryonic cell lines from domestic animals'
[patent_app_type] => new
[patent_app_number] => 10/175277
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6596
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175277
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175277 | Derivation of pluripotential embryonic cell lines from domestic animals | Jun 19, 2002 | Abandoned |
Array
(
[id] => 42005
[patent_doc_number] => 07780962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Treatment of neoplasms with RNA viruses'
[patent_app_type] => utility
[patent_app_number] => 10/167652
[patent_app_country] => US
[patent_app_date] => 2002-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 26838
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/780/07780962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10167652
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/167652 | Treatment of neoplasms with RNA viruses | Jun 12, 2002 | Issued |
Array
(
[id] => 7429262
[patent_doc_number] => 20040001808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Compositions and methods for the use of Bcl-2 transfected neurons'
[patent_app_type] => new
[patent_app_number] => 10/164965
[patent_app_country] => US
[patent_app_date] => 2002-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6259
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10164965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/164965 | Compositions and methods for the use of Bcl-2 transfected neurons | Jun 6, 2002 | Abandoned |
Array
(
[id] => 6846314
[patent_doc_number] => 20030165481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Amyloid peptide inactivating enzyme to treat Alzheimer\'s disease'
[patent_app_type] => new
[patent_app_number] => 10/159279
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14956
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10159279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/159279 | Amyloid peptide inactivating enzyme to treat Alzheimer's disease | Jun 2, 2002 | Abandoned |
Array
(
[id] => 6745687
[patent_doc_number] => 20030022870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Methods of treating cardiac disorders'
[patent_app_type] => new
[patent_app_number] => 10/161921
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12128
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161921 | Methods of treating cardiac disorders | Jun 2, 2002 | Abandoned |
Array
(
[id] => 448352
[patent_doc_number] => 07250294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-31
[patent_title] => 'Screening small molecule drugs using neural cells differentiated from human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/157288
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15243
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10157288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/157288 | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells | May 27, 2002 | Issued |
Array
(
[id] => 475513
[patent_doc_number] => 07226948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-05
[patent_title] => 'Treatment of neurodegenerative conditions with nimesulide'
[patent_app_type] => utility
[patent_app_number] => 10/150461
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 68
[patent_no_of_words] => 7168
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/226/07226948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150461
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150461 | Treatment of neurodegenerative conditions with nimesulide | May 16, 2002 | Issued |